BHCM
TECX

Brevan Howard Capital Management’s Tectonic Therapeutic TECX Stock Holding History

Brevan Howard Capital Management’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$329K Buy
+9,573
New +$281K ﹤0.01% 1660

Other funds holding TECX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Brevan Howard Capital Management's TECX Position: Q2 2026 in Review

Brevan Howard Capital Management opened a new position in Tectonic Therapeutic (TECX) in Q2 2026: 9,573 shares worth $329K. The stake represents ﹤0.01% of the portfolio and ranks #1660 among its holdings.

123 funds tracked by Wall St. Rank hold TECX as of Q2 2026.

  • Brevan Howard Capital Management held 9,573 shares of Tectonic Therapeutic worth $329K as of Q2 2026.
  • Tectonic Therapeutic was a new Brevan Howard Capital Management position in Q2 2026.
  • Tectonic Therapeutic made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #1660 holding.
  • 123 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.